Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that Vincent Renz has been appointed Chief Executive Officer and will join the Board of Directors, effective February 9, 2025.
Vincent Renz has over 30 years of leadership experience at C-Suite level, having served as CTO of eResearch Technology, CEO/COO of NewCardio, Inc, COO of Clinphone, Sr. Vice President, Client Services of Computron Software. Mr. Renz has served most recently as the President and Founder of Straight4ward Advisory Services – a boutique professional services company. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities.
The Company’s Chief Operating Officer, Tom Stein, stated “Leveraging Vinnie’s deep experiences and expertise in building operational excellence and public company leadership, we plan to partner and invest in businesses that are positioned to scale their proven models.” He added, “With Vinnie at the helm, we intend to assemble a seasoned management, advisory and operational team.”
Vincent Renz began his career with positions at Anderson Consulting and Deloitte focused on development and implementation of advanced technology solutions. He holds a BBA in Finance from the University of Notre Dame, as well as an MBA with a specialization in Information Technology from the Kelley School of Business at Indiana University.
Mr. Renz commented; “Over the last 40+ years, I’ve built highly efficient management teams which have enabled transformative technologies and brand development, and I look forward to replicating all of these experiences and relationships in partnering and investing in emerging growth opportunities.”
